Brief: Akoustis Q3 Fiscal 2023 Sales Growing Over 160% Year-Over-Year

Aktis Oncology

08/05/2023 15:35

May 8 (Reuters) - Akoustis Technologies Inc  AKTS.O :
    * AKOUSTIS REPORTS SIXTH CONSECUTIVE QUARTER OF RECORD
REVENUE
WITH THIRD QUARTER FISCAL 2023 SALES GROWING OVER 160%
YEAR-OVER-YEAR
    * QTRLY LOSS PER SHARE $0.23
    * QTRLY REVENUE $7.4 MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.19, REVENUE VIEW $7.5
MILLION --
REFINITIV IBES DATA
    * QTRLY ADJUSTED LOSS PER SHARE $0.20

Source text for Eikon:  ID:nGNX7sgdmX 
Further company coverage:  AKTS.O 

 ((Reuters.Briefs@thomsonreuters.com;))